FOLH1 and hepatocellular carcinoma: Meta-analysis of the available data looking at 68Ga-PSMA-11 found that the sensitivity of PSMA PET for HCC is high: 89.8% on the per-patient pooled analysis and 94.5% on the per-lesion pooled analysis.